An allosteric transport mechanism for the AcrAB-TolC Multidrug Efflux Pump
- Baylor College of Medicine, United States
- The University of Texas Health Science Center at Houston Medical School, United States
- MRC Mitochondrial Biology Unit, United Kingdom
- University of Cambridge, United Kingdom
Abstract
Bacterial efflux pumps confer multidrug resistance by transporting diverse antibiotics from the cell. In Gram-negative bacteria, some of these pumps form multi-protein assemblies that span the cell envelope. Here we report the near-atomic resolution cryoEM structures of the Escherichia coli AcrAB-TolC multidrug efflux pump in resting and drug transport states, revealing a quaternary structural switch that allosterically couples and synchronizes initial ligand binding with channel opening. Within the transport-activated state, the channel remains open even though the pump cycles through three distinct conformations. Collectively, our data provide a dynamic mechanism for the assembly and operation of the AcrAB-TolC pump.
Data availability
-
Crystal structure of AcrBZ complex: 2017Publicly available at PDB (accession no: 5NC5).
-
The apo structure of AcrAB-TolC tripartite multidrug efflux pump: 2017Publicly available at EBI Protein Data Bank (accession no: EMD-8636).
-
The asymmetric structure of AcrAB-TolC tripartite multidrug efflux pump: 2017Publicly available at EBI Protein Data Bank (accession no: EMD-8640).
-
The symmetric structure of AcrAB-TolC tripartite multidrug efflux pump with inhibitor MBX3132 bound: 2017Publicly available at EBI Protein Data Bank (accession no: EMD-3636).
-
The apo structure of AcrAB-TolC tripartite multidrug efflux pump: 2017Publicly available at PDB (accession no: 5V5S).
-
The asymmetric structure of AcrAB-TolC tripartite multidrug efflux pump: 2017Publicly available at PDB (accession no: 5V78).
-
The symmetric structure of AcrAB-TolC tripartite multidrug efflux pump with inhibitor MBX3132 bound: 2017Publicly available at PDB (accession no: 5NG5).
Article and author information
Author details
Funding
Wellcome
- Ben F Luisi
Human Frontier Science Program
- Ben F Luisi
National Institutes of Health (P41GM103832)
- Wah Chiu
American Heart Association (16GRNT29720001)
- Irina I Serysheva
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Olga Boudker, Weill Cornell Medical College, United States
Version history
- Received: January 5, 2017
- Accepted: March 14, 2017
- Accepted Manuscript published: March 29, 2017 (version 1)
- Version of Record published: April 25, 2017 (version 2)
Copyright
© 2017, Wang et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 12,330
- views
-
- 1,868
- downloads
-
- 180
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
An allosteric transport mechanism for the AcrAB-TolC Multidrug Efflux Pump
eLife 6:e24905.
https://doi.org/10.7554/eLife.24905
Further reading
-
- Structural Biology and Molecular Biophysics
Regulated hydrolysis of the phosphoinositide phosphatidylinositol(4,5)-bis-phosphate to diacylglycerol and inositol-1,4,5-P3 defines a major eukaryotic pathway for translation of extracellular cues to intracellular signaling circuits. Members of the lipid-activated protein kinase C isoenzyme family (PKCs) play central roles in this signaling circuit. One of the regulatory mechanisms employed to downregulate stimulated PKC activity is via a proteasome-dependent degradation pathway that is potentiated by peptidyl-prolyl isomerase Pin1. Here, we show that contrary to prevailing models, Pin1 does not regulate conventional PKC isoforms α and βII via a canonical cis-trans isomerization of the peptidyl-prolyl bond. Rather, Pin1 acts as a PKC binding partner that controls PKC activity via sequestration of the C-terminal tail of the kinase. The high-resolution structure of full-length Pin1 complexed to the C-terminal tail of PKCβII reveals that a novel bivalent interaction mode underlies the non-catalytic mode of Pin1 action. Specifically, Pin1 adopts a conformation in which it uses the WW and PPIase domains to engage two conserved phosphorylated PKC motifs, the turn motif and hydrophobic motif, respectively. Hydrophobic motif is a non-canonical Pin1-interacting element. The structural information combined with the results of extensive binding studies and experiments in cultured cells suggest that non-catalytic mechanisms represent unappreciated modes of Pin1-mediated regulation of AGC kinases and other key enzymes/substrates.
-
- Structural Biology and Molecular Biophysics
Roco proteins entered the limelight after mutations in human LRRK2 were identified as a major cause of familial Parkinson’s disease. LRRK2 is a large and complex protein combining a GTPase and protein kinase activity, and disease mutations increase the kinase activity, while presumably decreasing the GTPase activity. Although a cross-communication between both catalytic activities has been suggested, the underlying mechanisms and the regulatory role of the GTPase domain remain unknown. Several structures of LRRK2 have been reported, but structures of Roco proteins in their activated GTP-bound state are lacking. Here, we use single-particle cryo-electron microscopy to solve the structure of a bacterial Roco protein (CtRoco) in its GTP-bound state, aided by two conformation-specific nanobodies: NbRoco1 and NbRoco2. This structure presents CtRoco in an active monomeric state, featuring a very large GTP-induced conformational change using the LRR-Roc linker as a hinge. Furthermore, this structure shows how NbRoco1 and NbRoco2 collaborate to activate CtRoco in an allosteric way. Altogether, our data provide important new insights into the activation mechanism of Roco proteins, with relevance to LRRK2 regulation, and suggest new routes for the allosteric modulation of their GTPase activity.
